Antineoplastic agents from natural sources: achievements and future directions
Authors:
- 1 December 2000
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 9 (12) , 2783-2797
Abstract
The influence of natural products upon anticancer drug discovery and design cannot be overestimated. Approximately 60% of all drugs now in clinical trials for the multiplicity of cancers are either natural products, compounds derived from natural products, contain pharmacophores derived from active natural products or are ‘old drugs in new clothes’, where (modified) natural products are attached to targeting systems. This review covers those materials that the authors are aware of as being in clinical trials through early 2000 and demonstrates how, even today, in the presence of massive numbers of agents from combinatorial libraries, the compounds produced by ‘Mother Nature’ are still in the forefront of cancer chemotherapeutics as sources of active chemotypes.Keywords
This publication has 47 references indexed in Scilit:
- The influence of natural products upon drug discovery (Antiquity to late 1999)Natural Product Reports, 2000
- Marine natural productsNatural Product Reports, 2000
- Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor grooveProceedings of the National Academy of Sciences, 1999
- Identification of Sibling Species of the Bryozoan Bugula neritina That Produce Different Anticancer Bryostatins and Harbor Distinct Strains of the Bacterial Symbiont "Candidatus Endobugula sertula"The Biological Bulletin, 1999
- Speciation of Cone Snails and Interspecific Hyperdivergence of Their Venom Peptides: Potential Evolutionary Significance of IntronsaAnnals of the New York Academy of Sciences, 1999
- Natural Products in Drug Discovery and DevelopmentJournal of Natural Products, 1997
- Didemnin binds to the protein palmitoyl thioesterase responsible for infantile neuronal ceroid lipofuscinosis.Proceedings of the National Academy of Sciences, 1996
- Biomedical Potential of Marine Natural ProductsBioScience, 1996
- Docetaxel.Journal of Clinical Oncology, 1995
- Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosisNature Medicine, 1995